These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6437394)

  • 21. Inhibition of lens-aldose reductase activity by brazilin and haematoxylin.
    Moon CK; Yun YP; Lee JH; Wagner H; Shin YS
    Planta Med; 1985 Feb; (1):66-7. PubMed ID: 3925476
    [No Abstract]   [Full Text] [Related]  

  • 22. The distribution of aldose reductase and aldehyde reductase II in different regions of bovine lens.
    Liu S; Das B; Srivastava SK
    Lens Eye Toxic Res; 1989; 6(3):415-30. PubMed ID: 2518623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro expression of rat lens aldose reductase in Escherichia coli.
    Old SE; Sato S; Kador PF; Carper DA
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):4942-5. PubMed ID: 2114645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated and unactivated forms of human erythrocyte aldose reductase.
    Srivastava SK; Hair GA; Das B
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7222-6. PubMed ID: 3933003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of aldehyde and aldose reductases of human tissues to aldose reductase inhibitors.
    Srivastava SK; Petrash JM; Sadana IJ; Ansari NH; Partridge CA
    Curr Eye Res; 1982-1983; 2(6):407-10. PubMed ID: 6820339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localization of aldose reductase in the human eye.
    Akagi Y; Yajima Y; Kador PF; Kuwabara T; Kinoshita JH
    Diabetes; 1984 Jun; 33(6):562-6. PubMed ID: 6427040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irreversible aldose reductase inhibitors.
    Kador PF; Gurley RC; Ares JJ; Miller DD
    Prog Clin Biol Res; 1987; 232():353-65. PubMed ID: 3112788
    [No Abstract]   [Full Text] [Related]  

  • 28. Change in stereospecificity of bovine lens aldose reductase modified by oxidative stress.
    Del Corso A; Barsacchi D; Giannessi M; Tozzi MG; Camici M; Mura U
    J Biol Chem; 1989 Oct; 264(30):17653-5. PubMed ID: 2509445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel inhibitors of rat lens aldose reductase: N-[[(substituted amino)phenyl]sulfonyl]glycines.
    Mayfield CA; DeRuiter J
    J Med Chem; 1987 Sep; 30(9):1595-8. PubMed ID: 3114491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isoxazolidine-3,5-diones as lens aldose reductase inhibitors.
    Richon AB; Maragoudakis ME; Wasvary JS
    J Med Chem; 1982 Jun; 25(6):745-7. PubMed ID: 6808134
    [No Abstract]   [Full Text] [Related]  

  • 31. Ponalrestat: a potent and selective inhibitor of bovine lens aldose reductase.
    Tuffin DP; Dingle A; Sennitt CM; Mirrlees DJ; Ward WH
    Prog Clin Biol Res; 1989; 290():221-35. PubMed ID: 2498899
    [No Abstract]   [Full Text] [Related]  

  • 32. Residues affecting the catalysis and inhibition of rat lens aldose reductase.
    Carper DA; Hohman TC; Old SE
    Biochim Biophys Acta; 1995 Jan; 1246(1):67-73. PubMed ID: 7811733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of polyol pathway activity in diabetic and galactosemic rats by the aldose reductase inhibitor CP-45,634.
    Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
    Adv Exp Med Biol; 1979; 119():347-56. PubMed ID: 115231
    [No Abstract]   [Full Text] [Related]  

  • 34. [Substrate specificity and inhibition by various compounds of aldose reductase II from rabbit lens].
    Tanimoto T; Fukuda H; Kawamura J
    Yakugaku Zasshi; 1984 Jun; 104(6):631-4. PubMed ID: 6438300
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of aldose reductase inhibitors in vitro. Effects of enzyme purification and substrate type.
    Poulsom R
    Biochem Pharmacol; 1987 May; 36(10):1577-81. PubMed ID: 3109423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
    Tasaka H; Akagi Y; Yoshikawa T; Ikebe H; Takahashi Y; Chamoto K; Miyamoto Y; Terubayashi H
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens.
    Gonzalez AM; Sochor M; Hothersall JS; McLean P
    Diabetes; 1986 Nov; 35(11):1200-5. PubMed ID: 3093302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldose reductase and the etiology of diabetic cataracts.
    Varma SD
    Curr Top Eye Res; 1980; 3():91-155. PubMed ID: 6807610
    [No Abstract]   [Full Text] [Related]  

  • 39. Affinity purification and glucose specificity of aldose reductase from bovine lens.
    Inagaki K; Miwa I; Okuda J
    Arch Biochem Biophys; 1982 Jun; 216(1):337-44. PubMed ID: 6808928
    [No Abstract]   [Full Text] [Related]  

  • 40. Activation of aldose reductase from human tissues.
    Das B; Srivastava SK
    Diabetes; 1985 Nov; 34(11):1145-51. PubMed ID: 3930326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.